Angiotensin system inhibitor use is associated with longer survival in resected pancreatic cancer. (2021) - Liu, H.; D'Alesio, M.; Lebowitz, S.; Hammad, A.; Nassour, I.; Singhi, A.; Bahary, N.; Lee, K.; Zureikat, A.; Paniccia, A.